BB-Cl-Amidine as a novel therapeutic for canine and feline mammary cancer via activation of the endoplasmic reticulum stress pathway

[1]  R. Chen,et al.  Effects of DDIT4 in Methamphetamine-Induced Autophagy and Apoptosis in Dopaminergic Neurons , 2016, Molecular Neurobiology.

[2]  Paul McEwan,et al.  Development of a Selective Inhibitor of Protein Arginine Deiminase 2. , 2017, Journal of medicinal chemistry.

[3]  M. Radic,et al.  Current Challenges and Limitations in Antibody-Based Detection of Citrullinated Histones , 2016, Front. Immunol..

[4]  N. L. La Thangue,et al.  Abrogation of collagen-induced arthritis by a peptidyl arginine deiminase inhibitor is associated with modulation of T cell-mediated immune responses , 2016, Scientific Reports.

[5]  R. Harman,et al.  A Comparative Study on the In Vitro Effects of the DNA Methyltransferase Inhibitor 5-Azacytidine (5-AzaC) in Breast/Mammary Cancer of Different Mammalian Species , 2016, Journal of Mammary Gland Biology and Neoplasia.

[6]  T. Nakagawa,et al.  Anti-tumor effect of bevacizumab on a xenograft model of feline mammary carcinoma , 2015, The Journal of veterinary medical science.

[7]  P. Thompson,et al.  Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells. , 2015, Journal of visualized experiments : JoVE.

[8]  Sara M. Federico,et al.  Development and characterization of a human orthotopic neuroblastoma xenograft , 2015, Developmental biology.

[9]  L. Su,et al.  DDIT3 and KAT2A Proteins Regulate TNFRSF10A and TNFRSF10B Expression in Endoplasmic Reticulum Stress-mediated Apoptosis in Human Lung Cancer Cells* , 2015, The Journal of Biological Chemistry.

[10]  B. Pugh,et al.  ATF4 Gene Network Mediates Cellular Response to the Anticancer PAD Inhibitor YW3-56 in Triple-Negative Breast Cancer Cells , 2015, Molecular Cancer Therapeutics.

[11]  J. Hodgin,et al.  Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice , 2014, Annals of the rheumatic diseases.

[12]  P. Thompson,et al.  Chemical and biological methods to detect post‐translational modifications of arginine , 2014, Biopolymers.

[13]  L. Nonn,et al.  Selective Modulation of Endoplasmic Reticulum Stress Markers in Prostate Cancer Cells by a Standardized Mangosteen Fruit Extract , 2013, PloS one.

[14]  A. Garg,et al.  Targeting ER stress induced apoptosis and inflammation in cancer. , 2013, Cancer letters.

[15]  O. Griffith,et al.  Identification of PADI2 as a potential breast cancer biomarker and therapeutic target , 2012, BMC Cancer.

[16]  H. Ditzel,et al.  Functional Heterogeneity within the CD44 High Human Breast Cancer Stem Cell-Like Compartment Reveals a Gene Signature Predictive of Distant Metastasis , 2012, Molecular medicine.

[17]  P. Thompson,et al.  Potential Role of Peptidylarginine Deiminase Enzymes and Protein Citrullination in Cancer Pathogenesis , 2012, Biochemistry research international.

[18]  L. Anguish,et al.  Comparative analysis of peptidylarginine deiminase-2 expression in canine, feline and human mammary tumours. , 2012, Journal of comparative pathology.

[19]  L. Anguish,et al.  Potential Role for PAD2 in Gene Regulation in Breast Cancer Cells , 2012, PloS one.

[20]  J. Hurst-Kennedy,et al.  Ubiquitin C-Terminal Hydrolase L1 in Tumorigenesis , 2012, Biochemistry research international.

[21]  Jing Hu,et al.  Anticancer Peptidylarginine Deiminase (PAD) Inhibitors Regulate the Autophagy Flux and the Mammalian Target of Rapamycin Complex 1 Activity* , 2012, The Journal of Biological Chemistry.

[22]  D. Knapp,et al.  Effect of cyclooxygenase inhibitors in a xenograft model of canine mammary tumours. , 2011, Veterinary and comparative oncology.

[23]  P. Thompson,et al.  Protein arginine deiminase 4: a target for an epigenetic cancer therapy , 2011, Cellular and Molecular Life Sciences.

[24]  J. Stritzker,et al.  Significant Growth Inhibition of Canine Mammary Carcinoma Xenografts following Treatment with Oncolytic Vaccinia Virus GLV-1h68 , 2010, Journal of oncology.

[25]  K. Drobatz,et al.  Case-control study to evaluate risk factors for the development of sepsis (neutropenia and fever) in dogs receiving chemotherapy. , 2010, Journal of the American Veterinary Medical Association.

[26]  P. Agostinis,et al.  Linking ER Stress to Autophagy: Potential Implications for Cancer Therapy , 2010, International journal of cell biology.

[27]  P. Thompson,et al.  Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential. , 2009, Current opinion in drug discovery & development.

[28]  Risheng Ye,et al.  Role of the unfolded protein response regulator GRP78/BiP in development, cancer, and neurological disorders. , 2009, Antioxidants & redox signaling.

[29]  Jinxiang Han,et al.  Increased PADI4 expression in blood and tissues of patients with malignant tumors , 2009, BMC Cancer.

[30]  D. A. van der List,et al.  Characterization of a continuous feline mammary epithelial cell line susceptible to feline epitheliotropic viruses , 2009, Journal of Virological Methods.

[31]  G. Tortora,et al.  The use of xenograft models for the selection of cancer treatments with the EGFR as an example. , 2008, Critical reviews in oncology/hematology.

[32]  S. Groshen,et al.  Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. , 2008, Cancer research.

[33]  V. Adoue,et al.  Update on peptidylarginine deiminases and deimination in skin physiology and severe human diseases , 2007, International journal of cosmetic science.

[34]  W. Baumgärtner,et al.  Postoperative adjuvant treatment of invasive malignant mammary gland tumors in dogs with doxorubicin and docetaxel. , 2006, Journal of veterinary internal medicine.

[35]  Amy S. Lee,et al.  Glucose regulated proteins in cancer progression, Drug resistance and immunotherapy , 2006, Cancer biology & therapy.

[36]  Jinxiang Han,et al.  Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors , 2006, Molecular carcinogenesis.

[37]  S. Oyadomari,et al.  Roles of CHOP/GADD153 in endoplasmic reticulum stress , 2004, Cell Death and Differentiation.

[38]  E. Vossenaar,et al.  PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[39]  C. Novosad.  Principles of treatment for mammary gland tumors. , 2003, Clinical techniques in small animal practice.

[40]  A. Meyer‐Lindenberg,et al.  In vitro efficacy of chemotherapeutics as determined by 50% inhibitory concentrations in cell cultures of mammary gland tumors obtained from dogs. , 2001, American journal of veterinary research.

[41]  I. Fidler,et al.  Orthotopic Models are Necessary to Predict Therapy of Transplantable Tumors in Mice , 1998, Cancer and Metastasis Reviews.

[42]  P. Nowell,et al.  Progesterone augments proliferation induced by epidermal growth factor in a feline mammary adenocarcinoma cell line , 1991, Journal of cellular biochemistry.

[43]  E. Macewen,et al.  Spontaneous tumors in dogs and cats: Models for the study of cancer biology and treatment , 1990, Cancer and Metastasis Reviews.

[44]  R. Else,et al.  Studies of three canine mammary cell lines--II. In vivo properties. , 1984, European journal of cancer & clinical oncology.

[45]  R. Else,et al.  The characteristics of a canine mammary carcinoma cell line, REM 134. , 1982, British Journal of Cancer.

[46]  H. M. Hayes,et al.  Epidemiological features of feline mammary carcinoma , 1981, Veterinary Record.

[47]  S. Horibata,et al.  Role for peptidylarginine deiminase enzymes in disease and female reproduction. , 2012, The Journal of reproduction and development.

[48]  T. Ueno,et al.  LC3 and Autophagy. , 2008, Methods in molecular biology.

[49]  S. Patierno,et al.  Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions , 2004, Breast Cancer Research and Treatment.